4-127921956-C-G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001371596.2(MFSD8):​c.1006G>C​(p.Glu336Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00251 in 1,613,718 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E336K) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.0023 ( 1 hom., cov: 32)
Exomes š‘“: 0.0025 ( 12 hom. )

Consequence

MFSD8
NM_001371596.2 missense

Scores

2
11
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:5U:5B:6

Conservation

PhyloP100: 6.68

Publications

30 publications found
Variant links:
Genes affected
MFSD8 (HGNC:28486): (major facilitator superfamily domain containing 8) This gene encodes a ubiquitous integral membrane protein that contains a transporter domain and a major facilitator superfamily (MFS) domain. Other members of the major facilitator superfamily transport small solutes through chemiosmotic ion gradients. The substrate transported by this protein is unknown. The protein likely localizes to lysosomal membranes. Mutations in this gene are correlated with a variant form of late infantile-onset neuronal ceroid lipofuscinoses (vLINCL). [provided by RefSeq, Oct 2008]
MFSD8 Gene-Disease associations (from GenCC):
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis 7
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • macular dystrophy with central cone involvement
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.015144259).
BS2
High Homozygotes in GnomAdExome4 at 12 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001371596.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MFSD8
NM_001371596.2
MANE Select
c.1006G>Cp.Glu336Gln
missense
Exon 10 of 12NP_001358525.1Q8NHS3-1
MFSD8
NM_001371591.2
c.1006G>Cp.Glu336Gln
missense
Exon 10 of 12NP_001358520.1
MFSD8
NM_001371592.2
c.1012G>Cp.Glu338Gln
missense
Exon 10 of 12NP_001358521.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MFSD8
ENST00000641686.2
MANE Select
c.1006G>Cp.Glu336Gln
missense
Exon 10 of 12ENSP00000493218.2Q8NHS3-1
MFSD8
ENST00000296468.8
TSL:1
c.1006G>Cp.Glu336Gln
missense
Exon 11 of 13ENSP00000296468.3Q8NHS3-1
MFSD8
ENST00000945724.1
c.994G>Cp.Glu332Gln
missense
Exon 10 of 12ENSP00000615783.1

Frequencies

GnomAD3 genomes
AF:
0.00227
AC:
345
AN:
152134
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0116
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00294
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00243
AC:
610
AN:
250906
AF XY:
0.00236
show subpopulations
Gnomad AFR exome
AF:
0.000740
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0111
Gnomad NFE exome
AF:
0.00301
Gnomad OTH exome
AF:
0.00196
GnomAD4 exome
AF:
0.00254
AC:
3713
AN:
1461466
Hom.:
12
Cov.:
31
AF XY:
0.00242
AC XY:
1762
AN XY:
727046
show subpopulations
African (AFR)
AF:
0.000508
AC:
17
AN:
33472
American (AMR)
AF:
0.000112
AC:
5
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86232
European-Finnish (FIN)
AF:
0.0100
AC:
536
AN:
53388
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00273
AC:
3038
AN:
1111700
Other (OTH)
AF:
0.00192
AC:
116
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.443
Heterozygous variant carriers
0
185
369
554
738
923
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
116
232
348
464
580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00227
AC:
345
AN:
152252
Hom.:
1
Cov.:
32
AF XY:
0.00253
AC XY:
188
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.000505
AC:
21
AN:
41544
American (AMR)
AF:
0.00
AC:
0
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.0116
AC:
123
AN:
10586
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00294
AC:
200
AN:
68028
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00213
Hom.:
1
Bravo
AF:
0.00135
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00267
AC:
23
ExAC
AF:
0.00236
AC:
287
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00196
EpiControl
AF:
0.00231

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
2
not provided (4)
2
-
-
Macular dystrophy with central cone involvement (2)
-
1
1
Neuronal ceroid lipofuscinosis 7 (2)
-
1
-
Inborn genetic diseases (1)
-
-
1
Late-infantile neuronal ceroid lipofuscinosis (1)
-
-
1
MFSD8-related disorder (1)
-
1
-
Neuronal ceroid lipofuscinosis 7;C4015371:Macular dystrophy with central cone involvement (1)
-
-
1
not specified (1)
1
-
-
Optic atrophy (1)
1
-
-
Retinal disorder (1)
1
-
-
Retinal dystrophy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.39
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.11
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.45
T
Eigen
Uncertain
0.65
Eigen_PC
Uncertain
0.66
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.95
D
M_CAP
Uncertain
0.24
D
MetaRNN
Benign
0.015
T
MetaSVM
Uncertain
0.12
D
MutationAssessor
Uncertain
2.8
M
PhyloP100
6.7
PrimateAI
Benign
0.42
T
PROVEAN
Uncertain
-2.6
D
REVEL
Pathogenic
0.82
Sift
Uncertain
0.023
D
Sift4G
Benign
0.082
T
Polyphen
0.93
P
Vest4
0.78
MVP
0.82
MPC
0.43
ClinPred
0.061
T
GERP RS
5.2
Varity_R
0.41
gMVP
0.87
Mutation Taster
=64/36
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150418024; hg19: chr4-128843111; API